Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18034842rdf:typepubmed:Citationlld:pubmed
pubmed-article:18034842lifeskim:mentionsumls-concept:C0013072lld:lifeskim
pubmed-article:18034842lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:18034842lifeskim:mentionsumls-concept:C0025598lld:lifeskim
pubmed-article:18034842lifeskim:mentionsumls-concept:C0071097lld:lifeskim
pubmed-article:18034842lifeskim:mentionsumls-concept:C1524062lld:lifeskim
pubmed-article:18034842lifeskim:mentionsumls-concept:C1570906lld:lifeskim
pubmed-article:18034842pubmed:issue1lld:pubmed
pubmed-article:18034842pubmed:dateCreated2007-12-21lld:pubmed
pubmed-article:18034842pubmed:abstractTextThe aim of this study was to compare the efficacy and tolerability of vildagliptin vs. pioglitazone as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy.lld:pubmed
pubmed-article:18034842pubmed:languageenglld:pubmed
pubmed-article:18034842pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18034842pubmed:citationSubsetIMlld:pubmed
pubmed-article:18034842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18034842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18034842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18034842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18034842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18034842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18034842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18034842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18034842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18034842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18034842pubmed:statusMEDLINElld:pubmed
pubmed-article:18034842pubmed:monthJanlld:pubmed
pubmed-article:18034842pubmed:issn1463-1326lld:pubmed
pubmed-article:18034842pubmed:authorpubmed-author:BolliGGlld:pubmed
pubmed-article:18034842pubmed:authorpubmed-author:CohenS ESElld:pubmed
pubmed-article:18034842pubmed:authorpubmed-author:DottaFFlld:pubmed
pubmed-article:18034842pubmed:authorpubmed-author:RochotteEElld:pubmed
pubmed-article:18034842pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18034842pubmed:volume10lld:pubmed
pubmed-article:18034842pubmed:ownerNLMlld:pubmed
pubmed-article:18034842pubmed:authorsCompleteYlld:pubmed
pubmed-article:18034842pubmed:pagination82-90lld:pubmed
pubmed-article:18034842pubmed:dateRevised2009-11-3lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:meshHeadingpubmed-meshheading:18034842...lld:pubmed
pubmed-article:18034842pubmed:year2008lld:pubmed
pubmed-article:18034842pubmed:articleTitleEfficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study.lld:pubmed
pubmed-article:18034842pubmed:affiliationSection of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy.lld:pubmed
pubmed-article:18034842pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18034842pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:18034842pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18034842pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18034842lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18034842lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18034842lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18034842lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18034842lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18034842lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18034842lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18034842lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18034842lld:pubmed